About Teva Api India Private Limited
Data last updated:
Teva Api India Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Teva Pharmaceuticals Finance Netherlands Bv. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 26 April 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74899MH2002PTC326704. Its GSTIN is 27AACCR0679R1ZN (Maharashtra). The company holds 6 GST registrations, of which 4 are active.
The company has an authorised share capital of ₹1,400 Cr and a paid-up capital of ₹513.89 Cr. It was formerly known as Teva Api India Limited. and Regent Drugs Limited. It is led by directors including Vinay Kumar Sharma and Muneshvar Singh.
Its last annual general meeting (AGM) was held on 17 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹1,456.07 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹34.53 Cr (net margin 2.4%) and EBITDA of ₹256.98 Cr (EBITDA margin 17.6%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 6% over five years.
The company has about 1,119 employees on its provident fund (EPFO) records.
Court records list 23 cases involving the company, including 12 filed by the company and 11 filed against it; 7 cases are pending. The company has 10 deals on record (7 funding rounds, 3 secondary share transfers), with disclosed funding of ₹1,661.73 Cr; the latest was in March 2021. Its 3 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 1 larger and 2 smaller; the largest is Viyash Life Sciences Private Limited with revenue of ₹1,482.68 Cr. The company has 15 MSME Form 1 returns on record between 2017 and 2023, listing 592 overdue payments to 152 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tevapharm.in.
Company details
Name history
Teva Api India has undergone 2 name changes throughout its history. The company was previously known as Teva Api India Limited., and Regent Drugs Limited. The current legal name is Teva Api India Private Limited.
| Company Name | Status |
|---|---|
| Teva Api India Private Limited | Current |
| Teva Api India Limited. | Previous |
| Regent Drugs Limited | Previous |
CIN history
Teva Api India has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U74899MH2002PTC326704, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74899MH2002PTC326704 | Current |
| U74899DL2002PTC138679 | Previous |
| U74899DL2002PLC138679 | Previous |
Contact details
Teva Api India Private Limited's registered office is in Mumbai, Maharashtra. Its website is tevapharm.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address8th Floor Tower C Times Square Andheri Kurla Road Gamdevi Marol Andh, Eri East, Mumbai, Maharashtra, India – 400059
- IndustryPharma, API Manufacturers
To see the full contact details of Teva Api India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Teva Api India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Teva Api India Private Limited, buy the company report.
Financials of Teva Api India Private Limited
FY 2025 filings availableTeva Api India Private Limited reported revenue of ₹1,456.07 Cr (up 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 7% growth in the latest year. EBITDA rose 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹256.98 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹34.53 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.6% | ||||
| Net Profit Margin | 2.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Teva Api India Private Limited, buy the company report.
Board of directors of Teva Api India Private Limited
Teva Api India has 4 current directors and 21 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vinay Kumar Sharma | Director | 04 Jun 2021 | 5 Years 5 Months | Current |
| Muneshvar Singh | Director | 28 Mar 2020 | 6 Years 7 Months | Current |
| Rohan Yogesh Overseer | Director | 12 Mar 2025 | 1 Years 8 Months | Current |
| Arun Thiruselvam | Director | 12 Mar 2025 | 1 Years 8 Months | Current |
Peer comparison
Teva Api India Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Viyash Life Sciences Private Limited | ₹1,482.68 Cr (FY 2025) | 9.0% | Hyderabad, Telangana, India | |||
| Teva Api India Private Limitedthis company | ₹1,456.07 Cr (FY 2025) | ₹34.53 Cr | 2.4% | 7.0% | 1,119 | Mumbai, Maharashtra, India |
| Cohance Lifesciences Limited | ₹1,362.25 Cr (FY 2024) | 0.0% | Mumbai, Maharashtra, India | |||
| Arch Pharmalabs Limited | ₹1,344.16 Cr (FY 2023) | 2.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Teva Api India Private Limited, buy the company report.
Auditor
Teva Api India Private Limited is audited by MSKA & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MSKA & Associates | FY 2023 | 105047W |
Shareholding
The shareholding of Teva Api India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Teva Api India Private Limited, buy the company report.
Deals & funding
Teva Api India Private Limited has 10 deals on record (7 funding rounds, 3 secondary share transfers), with disclosed funding of ₹1,661.73 Cr; the latest was in March 2021.
Deals on record (5 of 10)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2021 | Secondary share transfer | Undisclosed | Seller: Teva Pharmaceutical Finance Netherlands B V |
| Jul 2019 | Funding round | ₹457.35 Cr | Investors: Lotus Labs Private Limited , Teva Pharmaceutical and Chemical Industries India Private Limited , Tevapharm India Private Limited |
| Jun 2019 | Secondary share transfer | Undisclosed | Seller: Teva Pharmaceutical Finance Netherlands B V |
| Mar 2019 | Secondary share transfer | Undisclosed | Seller: Teva Pharmaceutical Finance Netherlands B V |
| Jun 2008 | Funding round | ₹55.29 Cr | Investors: Teva Pharmaceutical Finance Netherlands B V |
To see the full deal history of Teva Api India Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Teva Api India Private Limited has 23 court cases on record: 12 filed by Teva Api India, 11 filed against it. 7 cases are pending and 16 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 11 | 9 | 1 |
| High courts | 8 | 2 | 6 |
| Supreme Court | 4 | 0 | 0 |
Cases on record (5 of 23)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Jhajjar, Haryana | Court case (Rsuit) | Filed against the company by M/S Zeco Aircon Ltd Through Anand Kumar Gupta | Pending |
| High Court of Madhya Pradesh | Appeal | Filed against the company by Surya Roshni Limited Malanpur Th: President B.K.Behera | Pending |
| District court, Central, Delhi | Civil suit | Filed against the company by National Insurance Co.Ltd. and Anr. | Disposed |
| District court, West, Delhi | Court case (Civ DJ) | Filed by the company against Om Logistics Limited | Disposed |
| District court, South, Delhi | Civil suit | Filed against the company by Matrix Cellular (International) Services Ltd. | Disposed |
To see the full case history of Teva Api India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Teva Api India Private Limited has 15 MSME Form 1 returns on record between 2017 and 2023, listing 592 overdue payments to 152 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 152)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Teva Api India Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Teva Api India Private Limited has a workforce of 1,119 employees on its EPFO records as of May 2026, across 2 active EPFO establishments.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 1,119 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Teva Api India Private Limited, buy the company report.
GST
Teva Api India has 6 GST registrations: 4 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCR0679R1ZN | Maharashtra | Active | 01 Jul 2020 |
| 27AACCR0679R2ZM | Maharashtra | Active | 21 Mar 2025 |
| 09AACCR0679R1ZL | Uttar Pradesh | Active | 01 Jul 2017 |
| 23AACCR0679R1ZV | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Teva Api India Private Limited, buy the company report.
Recent activity
Teva Api India Private Limited has 42 board changes on record since 2003: 23 appointments and 19 cessations. The latest: Nishank Bhargava ceased to be Director on 01 Jul 2025.
33 earlier events are in the company report.
Frequently asked questions
Teva Api India is an active private limited company based in Mumbai, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 26 April 2002 (24+ years old) and is registered under CIN U74899MH2002PTC326704.
Teva Api India has 4 current directors:
- Vinay Kumar Sharma - Director
- Muneshvar Singh - Director
- Rohan Yogesh Overseer - Director
- Arun Thiruselvam - Director
The latest financial statements of Teva Api India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 17 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Teva Api India is 27AACCR0679R1ZN, registered in Maharashtra. The company has 6 GST registrations in all, of which 4 are active and 2 are cancelled or inactive. Other active GSTINs include 27AACCR0679R2ZM (Maharashtra), 09AACCR0679R1ZL (Uttar Pradesh), 23AACCR0679R1ZV (Madhya Pradesh).
The CIN (Corporate Identification Number) of Teva Api India is U74899MH2002PTC326704. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Teva Api India has 23 court cases on record: 12 filed by the company and 11 filed against it. 7 are pending. Most are in the district courts.
Teva Api India was incorporated on 26 April 2002, making it 24+ years old. It is registered with the Registrar of Companies, Mumbai.
Teva Api India has 10 deals on record (7 funding rounds, 3 secondary share transfers), with disclosed funding of ₹1,661.73 Cr; the latest was in March 2021.
The peers of Teva Api India by revenue are Viyash Life Sciences Private Limited, Cohance Lifesciences Limited, Arch Pharmalabs Limited, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Nishank Bhargava ceased to be Director on 01 Jul 2025. Arun Thiruselvam was appointed as Director on 12 Mar 2025. Rohan Yogesh Overseer was appointed as Director on 12 Mar 2025. Teva Api India has 42 board changes on record in total.
Teva Api India has 15 MSME Form 1 returns on record between 2017 and 2023, listing 592 overdue payments to 152 micro and small suppliers. The latest return was filed on 02 Jan 2024.
Teva Api India can be reached through the website tevapharm.in. Its registered office is in Mumbai, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
